| Source NDC Code |
|
Target HCPCS Code |
68727-0900-03
RYLAZE 10 MG/0.5 ML VIAL
|
⇄
|
J9021
Inj, aspara, rylaze, 0.1 mg
|
| Detail Information |
| Relationship Start Date |
01/03/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IM |
| Billing Units |
ML |
|
|
|
68727-0900-03
RYLAZE 10 MG/0.5 ML VIAL
|
⇄
|
J9999
NOT OTHERWISE CLASSIFIED, ANTINEOPLASTIC DRUGS
|
| Detail Information |
| Relationship Start Date |
10/01/2021 |
| Relationship End Date |
12/31/2021 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IM |
| Billing Units |
ML |
|
|
|
68727-0900-03
Rylaze
|
⇄
|
J9021
Inj, aspara, rylaze, 0.1 mg
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|